68 Ga-DOTATATE and 18 F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity

Chian A Chang , David A Pattison , Richard W Tothill , Grace Kong
Cancer Imaging 16 ( 1) 22

144
2016
Next-Generation Sequence Analysis of Cancer Xenograft Models

Richard W. Tothill , Kara Britt , Kieren D. Marini , Jeanette Falzon
PLoS ONE 8 ( 9) e74432

31
2013
Development and validation of a gene expression tumour classifier for cancer of unknown primary.

Richard W. Tothill , Fan Shi , Lisa Paiman , Justin Bedo
Pathology 47 ( 1) 7 -12

25
2015
Options available--from start to finish--for obtaining data from DNA microarrays II.

Andrew J. Holloway , Ryan K. van Laar , Richard W. Tothill , David D.L. Bowtell
Nature Genetics 32 ( 32) 481 -489

381
2002
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late

Maarten J. IJzerman , Jasper de Boer , Arun Azad , Koen Degeling
Diagnostics (Basel, Switzerland) 11 ( 1) 103

28
2021
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads

Jan Schröder , Arthur Hsu , Samantha E. Boyle , Geoff Macintyre
Bioinformatics 30 ( 8) 1064 -1072

63
2014
MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers

Georgina L. Ryland , Jennifer L. Bearfoot , Maria A. Doyle , Samantha E. Boyle
PLoS ONE 7 ( 4) e35805

24
2012
Loss of heterozygosity: what is it good for?

Georgina L. Ryland , , Maria A. Doyle , David Goode
BMC Medical Genomics 8 ( 1) 45 -45

141
2015
BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

Victoria J. Mar , Stephen Q. Wong , Jason Li , Richard A. Scolyer
Clinical Cancer Research 19 ( 17) 4589 -4598

88
2013
10
2020
CONTRA: copy number analysis for targeted resequencing

Jason Li , Richard Lupat , Kaushalya C. Amarasinghe , Ella R. Thompson
Bioinformatics 28 ( 10) 1307 -1313

336
2012
Navigating the Challenge of Tumor Heterogeneity in Cancer Therapy

Clare Fedele , Richard W. Tothill , Grant A. McArthur
Cancer Discovery 4 ( 2) 146 -148

42
2014
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas

Grant A. McArthur , Anthony T. Papenfuss , Richard A. Scolyer , Anthony J. Gill
Cancer Research 75 ( 24) 5228 -5234

294
2015
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion

David Y. Choong , David J. Byrne , Amir Iravani , Sophie Beck
Journal of Clinical Investigation 129 ( 5) 1940 -1945

14
2019
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.

Stephen Q. Wong , Jason Li , Renato Salemi , Karen E. Sheppard
Scientific Reports 3 ( 1) 3494 -3494

37
2013
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

Marian L. Burr , Christina E. Sparbier , Kah Lok Chan , Yih-Chih Chan
Cancer Cell 36 ( 4) 385 -401

281
2019
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

Ella R. Thompson , Maria A. Doyle , Georgina L. Ryland , Simone M. Rowley
PLOS Genetics 8 ( 9)

146
2012
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

Marcus Lefebure , Richard W. Tothill , Elizabeth Kruse , Edwin D. Hawkins
Nature Communications 8 ( 1) 14581 -14581

18
2017
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue

Tanjina Kader , David L. Goode , Stephen Q. Wong , Jacquie Connaughton
Genome Medicine 8 ( 1) 121 -121

23
2016